20 Apr 2021
// Max Gelman ENDPTS
https://endpts.com/ovid-cuts-its-losses-on-controversial-angelman-syndrome-drug-making-its-crushing-development-halt-permanent/
27 Mar 2015
// Ben Fidler XCONOMY
http://www.xconomy.com/new-york/2015/03/25/ex-teva-ceo-levin-is-back-with-startup-aimed-at-rare-neuro-disorders/
LOOKING FOR A SUPPLIER?